NASDAQ · Medical - Care Facilities

ASTH (ASTH) Stock

$38.57 -0.08% NASDAQ: ASTH Healthcare

Valuation

MetricValue
Price$38.57
Market Cap$1.91B
P/E Ratio46.05
P/B Ratio2.25
P/S Ratio0.49
EPS (TTM)$0.46
52-Week High$51.60
52-Week Low$18.08
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE5.09%
ROA1.78%
ROCE6.55%
Gross Margin9.30%
Operating Margin2.47%
Net Margin1.05%
Debt/Equity1.18
Current Ratio1.40

Annual Financials (USD)

Metric20212022202320242025
Revenue$774.0M$1.1B$1.4B$2.0B$3.2B
Operating Profit$98.0M$104.0M$85.0M$89.0M$79.0M
Net Profit$69.0M$45.0M$61.0M$43.0M$22.0M
EPS$1.52$0.99$1.29$0.90$0.46
Op Margin12.7%9.1%6.1%4.4%2.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$867.0M$966.0M$933.0M$1.4B$2.2B
Total Liabilities$357.0M$408.0M$523.0M$841.0M$1.7B
Cash$233.0M$288.0M$294.0M$288.0M$429.0M
Borrowings$201.0M$229.0M$321.0M$472.0M$1.1B

Latest News

Astrana Health (ASTH) Stock Looks Fully Valued Following Its 87% Run Simply Wall St. · Jul 16, 2026 2 Reasons to Like ASTH and 1 to Stay Skeptical StockStory · Jul 15, 2026 ASTH: Raising target price to $51.00 Argus Research · Jul 15, 2026 Astrana Health, Inc. Schedules 2026 Second Quarter Financial Results Release and Conference Call PR Newswire · Jul 14, 2026 Astrana Health Strengthens Leadership Team to Accelerate Long-Term Growth PR Newswire · Jul 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$70.0M$82.0M$68.0M$52.0M$115.0M
Investing Cash Flow$-3.0M$-30.0M$-94.0M$-200.0M$-549.0M
Financing Cash Flow$-7.0M$-5.0M$-15.0M$-14.0M$-28.0M
Net Cash Flow$39.0M$55.0M$6.0M$-5.0M$145.0M
Free Cash Flow$51.0M$59.0M$40.0M$44.0M$104.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.81
EV / EBITDA14.11
FCF Yield8.38%
Quick Ratio1.23
Interest Coverage1.49
Return 1Y82.67%
Return 3Y21.67%
Return 5Y-62.83%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACHC $27.75 -1.77% -2.21 $2.58B 0.00%
AVAH $13.20 -1.93% 5.98 $2.87B 0.00%
HCSG $21.77 -0.23% 23.69 $1.49B 0.00%
LFST $12.89 +2.30% 390.00 $5.00B 0.00%
MD $26.86 +1.47% 11.87 $2.21B 0.00%

About ASTH

ASTH stock trades at $38.57 with a market capitalization of $1.91B. The stock is valued at a price-to-earnings (P/E) ratio of 46.05, price-to-book of 2.25, price-to-sales of 0.49. Over the past 52 weeks the stock has ranged between $18.08 and $51.60, and currently trades 25.3% below its 52-week high.

On profitability, ASTH generates a return on equity (ROE) of 5.09%, return on capital employed of 6.55%, an operating margin of 2.47%, a net profit margin of 1.05%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1160.06 +0.01% JNJ Drug Manufacturers - General $275.21 +1.48% ABBV Drug Manufacturers - General $261.70 +0.66% MRK Drug Manufacturers - General $151.64 +1.19% UNH Medical - Healthcare Plans $399.66 +0.85% NVS Drug Manufacturers - General $162.46 +0.75% AZN Drug Manufacturers - General $161.63 -0.52% AMGN Drug Manufacturers - General $442.84 +1.08% TMO Medical - Diagnostics & Research $608.54 +1.34% NVO Biotechnology $46.77 +3.66% ABT Medical - Devices $110.49 +1.43% GILD Drug Manufacturers - General $149.61 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides